Quercetin
The everyday flavonoid that became half of the first human senolytic.
Quercetin is the most abundant flavonol in the human diet — concentrated in onions, capers, apples, and berries — and it pulls double duty in longevity research. It is a broad anti-inflammatory and antioxidant with decades of study, and it is the Q in 'D+Q', the dasatinib-plus-quercetin combination that became the first senolytic regimen tested in humans, where early pilot trials showed reduced senescent-cell markers. The combination evidence is early and quercetin alone is no proven senolytic — but few food compounds sit this close to aging research's front line.
How Quercetin affects aging
Quercetin's senolytic story began with a 2015 transcriptome analysis showing that senescent cells survive by leaning on specific pro-survival pathways — their Achilles' heel. Quercetin, which dampens several of those pathways, selectively killed senescent human endothelial cells; the leukemia drug dasatinib killed senescent fat-cell progenitors; together they covered more senescent cell types than either alone. In aged mice, a single dose of the combination improved cardiac function, and periodic treatment extended healthspan and delayed age-related decline. Quercetin earned its place in aging research as one half of that first senolytic cocktail.
Its second, older identity is as a broad anti-inflammatory. Quercetin restrains NF-kB, the master switch of inflammatory gene expression, stabilizes mast cells that release histamine, and scavenges free radicals directly while supporting the body's own antioxidant enzymes. This portfolio makes it relevant to inflammaging — the chronic low-grade inflammation that accelerates most age-related diseases — and underlies the long-running interest in quercetin for blood pressure, endothelial function, and allergy symptoms, where human trial results have been mixed but mechanistically consistent.
The human senolytic evidence is real but must be read carefully. Two small open-label pilots of dasatinib plus quercetin — one in idiopathic pulmonary fibrosis showing improved physical function, one in diabetic kidney disease showing reduced senescent-cell burden in tissue within days — are the first demonstrations that senolytics can work in people. Both were tiny, uncontrolled, and used a chemotherapy drug alongside quercetin. Quercetin by itself, at supplement doses, has not been shown to clear senescent cells in humans.
Dosage
RDA: No official RDA established. Typical Western intake is roughly 10-20mg per day, mostly from onions, apples, tea, and berries.
Optimal for longevity: No target is established. Supplement trials commonly use 500-1,000mg daily for general endpoints; senolytic research uses about 1,000-1,250mg on a few consecutive days — but always combined with dasatinib, a prescription drug, under trial conditions. For everyday purposes, researchers point to consistently flavonoid-rich meals rather than a number.
Food first: red and yellow onions (the outer rings are richest), capers, apples with skin, berries, kale, and tea can plausibly triple a low baseline intake. A practical bonus: the quercetin glucosides in onions are absorbed better than the pure aglycone found in most capsules, so food is not just the safer route but a surprisingly efficient one.
If you supplement, know quercetin's weakness: poor bioavailability. The standard aglycone is badly absorbed and quickly metabolized — taking it with a fat-containing meal helps, and phytosome or lecithin formulations absorb substantially better. Typical doses are 500-1,000mg daily in trials. Do not attempt DIY senolytic protocols: the human data involve prescription dasatinib and clinical supervision. Quercetin can also interact with certain drugs, so check with a pharmacist.
Deficiency signs
No deficiency metric; intake tracks fruit and vegetable habits and is lowest in produce-poor, heavily processed diets
- No deficiency syndrome — quercetin is not an essential nutrient
- Diets low in onions, apples, berries, and tea provide little
- Low flavonoid intake patterns correlate with higher cardiovascular risk in cohort studies
- Produce-poor diets miss quercetin alongside fiber and other polyphenols
- Intake is hard to judge without tracking, since content varies by food and preparation
Top food sources
What the research shows
The discovery paper for senolytics: senescent cells depend on pro-survival networks, and dasatinib plus quercetin selectively eliminated them while sparing healthy cells. In aged mice, a single dose improved cardiac function and exercise capacity, and periodic dosing extended healthspan and delayed age-related symptoms. Foundational, but animal evidence.
In 14 patients with IPF, three weeks of intermittent dasatinib (100mg) plus quercetin (1,250mg) was feasible and associated with clinically meaningful gains in six-minute walk distance, gait speed, and chair-stand performance. Open-label, no control group — a proof-of-concept, not proof of efficacy.
A three-day course of dasatinib (100mg) plus quercetin (1,000mg) reduced senescent-cell markers (p16, p21) in fat and skin tissue and lowered circulating SASP inflammatory factors within 11 days — the first direct evidence that senolytics clear senescent cells in living humans. Small, preliminary, and combination-only.
Frequently asked questions
Does quercetin alone clear senescent cells?
Not proven. In the lab, quercetin alone kills only certain senescent cell types; every human result so far used it combined with dasatinib, a prescription chemotherapy drug. Taking quercetin capsules is not a senolytic protocol.
What are the best food sources of quercetin?
Onions — especially red onions and the outer layers — plus capers, apples with skin, berries, kale, and tea. Onion quercetin comes as glucosides, which absorb better than the pure form in most supplements.
How can I improve quercetin absorption?
Take it with a meal containing fat, or choose a phytosome/lecithin formulation, which raises blood levels substantially versus plain quercetin. Plain aglycone powder on an empty stomach is the least effective option.
Should quercetin be taken daily or intermittently?
Depends on the goal. For general anti-inflammatory support, trials use continuous daily dosing. Senolytic research deliberately uses short intermittent bursts — but that evidence involves the D+Q combination under medical supervision, not solo supplementation.
Is quercetin safe, and does it interact with medications?
Food amounts are unquestionably safe, and 500-1,000mg daily has been well tolerated in trials for up to 12 weeks. It can inhibit drug-metabolizing enzymes and transporters, potentially affecting certain antibiotics, blood thinners, and other medications — check with a pharmacist if you take prescriptions.
Track your quercetin intake
Biohack logs quercetin alongside 22 other longevity nutrients in every meal.